Skip to main content
Back
Watch Compare

IMMUNIC, INC.

Data quality: 83%
IMUX
Nasdaq Manufacturing Chemicals
$1.17
▼ $0.12 (-9.30%)
Mkt Cap: 168.30 M
Price
$1.29
Mkt Cap
168.30 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -85.97 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-437.61%
Below sector avg (-53.34%)
ROIC-364.54%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio1.31
Interest CoverageN/A

Valuation

PE (TTM)
-1.73
Below sector avg (-1.47)
P/B Ratio16.03
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -1.7 -1.5
P/B 16.0 1.6
ROE % -437.6 -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

8 analysts
Buy
Current
$1.17
+348.7%
Target
$5.25
$3.00
$4.50
$10.00
Forecast
Forward P/E -3.37
Forward EPS -$0.35
Est. Revenue 10.26 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.35
-$0.52 – -$0.09
 10.26 M 7
FY2026 -$0.42
-$0.64 – -$0.21
 0.0 8

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.12 -$0.07 +39.8%
Q32025 -$0.18 -$0.13 +26.4%
Q22025 -$0.16 -$0.20 -26.3%
Q12025 -$0.24 -$0.25 -4.2%

ETFs Holding This Stock

BRSIX BRSIX
0.13% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -97.17 M
ROE -437.61% ROA -190.29%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -85.97 M
ROIC -364.54% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.31
Interest Coverage N/A Asset Turnover N/A
Working Capital 9.19 M Tangible Book Value 10.50 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.73 Forward P/E N/A
P/B Ratio 16.03 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -51.08%
Market Cap 168.30 M Enterprise Value 133.17 M
Per Share
EPS (Diluted TTM) -0.62 Revenue / Share N/A
FCF / Share -0.66 OCF / Share -0.66
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 88.47%
SBC-Adj. FCF -95.43 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -97.17 M -100.51 M -93.61 M -120.41 M -92.95 M
EPS (Diluted) -0.62 -1.00 -2.11 -3.78 -3.93
Gross Profit — — — — —
Operating Income -103.23 M -98.05 M -99.22 M -119.49 M -91.67 M
EBITDA — — — — —
R&D Expenses 81.98 M 80.05 M 83.22 M 71.26 M 61.12 M
SG&A Expenses — — — — —
D&A 168,000.0 134,000.0 111,000.0 77,000.0 85,000.0
Interest Expense — — — — —
Income Tax 0.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 24.05 M 40.87 M 54.30 M 127.75 M 139.10 M
Total Liabilities 30.73 M 22.44 M 25.37 M 14.07 M 11.99 M
Shareholders' Equity -6.67 M 18.43 M 28.93 M 113.68 M 127.12 M
Total Debt — — — — —
Cash & Equivalents 15.48 M 35.67 M 46.67 M 106.75 M 86.86 M
Current Assets 22.87 M 39.33 M 52.53 M 125.86 M 104.99 M
Current Liabilities 30.62 M 22.18 M 24.73 M 13.08 M 11.40 M